Table 3. Comparison of clinical variables and HRQoL between type D and non-type D fibromyalgia patients.
| Type D FM patients (n=33) | Non-type D FM patients (n=67) | p | |
| Mean±SD | Mean±SD | ||
| Pain (VAS, 10 cm) | 8.6±0.8 | 5.8±1.2 | <0.00001* |
| Fatigue (VAS, 10 cm) | 4.5±3.2 | 4.0±3.5 | 0.6 |
| Tender point count | 15.7±2.3 | 12.9±1.9 | <0.00001* |
| Fibromyalgia impact questionnaire | 86.3±8.4 | 64.1±11.4 | <0.00001* |
| Stanford health assessment questionnaire | 1.2±0.8 | 0.5±0.5 | <0.00001* |
| NHP-pain | 89.2±10.7 | 64.3±14.1 | <0.00001* |
| NHP-physical mobility | 53.4±16.9 | 22.6±21.0 | <0.00001* |
| NHP-energy | 45.5±42.1 | 37.3±41.1 | 0.358 |
| NHP-sleep | 80.0±19.4 | 56.2±22.6 | <0.00001* |
| NHP-social isolation | 60.6±37.2 | 15.5±25.1 | <0.00001* |
| NHP-emotional reactions | 83.7±14.1 | 51.5±25.1 | <0.00001* |
| HRQoL: Health-related quality of life; FM: Fibromyalgia; SD: Standard deviation; VAS: Visual analog scale; NHP: Nottingham Health Profile; * p<0.01 was considered statistically significant. | |||